Market Place
Sourcing Support
Prothena Presents Data Supporting Next Gen Parkinsons & AD
23 Mar 2026 //
BUSINESSWIRE
Prothena Announces Up To $100 Million Share Repurchase Plan
27 Feb 2026 //
BUSINESSWIRE
Prothena Reports Q4 & Full Year 2025 Financial Results
19 Feb 2026 //
BUSINESSWIRE
Prothena Reports Q4, FY 2025 Results on Feb. 19, 2026
12 Feb 2026 //
BUSINESSWIRE
Prothena Announces Board Of Directors Update
12 Dec 2025 //
BUSINESSWIRE
Prothena Announces Poster Presentation on TDP-43 CYTOPE Program
19 Nov 2025 //
BUSINESSWIRE
Prothena Showcases Coramitug Phase 2 Results of AHA
11 Nov 2025 //
BUSINESSWIRE
Prothena Unveils Q3 2025 Financials & Key Achievements
06 Nov 2025 //
BUSINESSWIRE
Prothena To Release Q3 2025 Financial Results On November 6
30 Oct 2025 //
BUSINESSWIRE
Bristol Myers Squibb Secures FDA Fast Track For BMS-986446
01 Oct 2025 //
BUSINESSWIRE
Prothena to Present at Cantor Fitzgerald Global Health Conference
28 Aug 2025 //
BUSINESSWIRE
Prothena Alzheimer’s Drug Shows Familiar Side Effect in Ph 1 Test
28 Aug 2025 //
BIOSPACE
Prothena`s Q2 2025 Financial Results Due August 4
28 Jul 2025 //
BUSINESSWIRE
Prothena`s Phase 3 AFFIRM-AL Trial for Birtamimab Misses Endpoint
23 May 2025 //
BUSINESSWIRE
Prothena to Report First Quarter 2025 Financial Results on May 8
01 May 2025 //
BUSINESSWIRE
Prothena Announces Board of Directors Update
30 Dec 2024 //
BUSINESSWIRE
Roche`s Prothena-partnered Parkinson`s prospect fails phase 2b
19 Dec 2024 //
FIERCE BIOTECH
Roche’s Prothena-partnered Parkinson’s prospect fails phase 2b
19 Dec 2024 //
FIERCE BIOTECH
Prothena Reports Q3 2024 Financial Results and Business Highlights
12 Nov 2024 //
BUSINESSWIRE
Prothena to Report Q3 2024 Financial Results on November 12
05 Nov 2024 //
BUSINESSWIRE
Prothena Announces Leadership Team Updates
27 Sep 2024 //
BUSINESSWIRE
Prothena to Participate in Upcoming Healthcare Conferences
29 Aug 2024 //
BUSINESSWIRE
Prothena Reports Second Quarter 2024 Financial Results and Business Highlights
08 Aug 2024 //
BUSINESSWIRE
Prothena to Report Second Quarter 2024 Financial Results on August 8
01 Aug 2024 //
BUSINESSWIRE
Prothena: Birtamimab Review Published In Leukemia & Lymphoma
15 Apr 2024 //
BUSINESSWIRE
Biotech Firm Prothena Is Said to Prepare for Potential Sale
16 Oct 2023 //
BLOOMBERG
Prothena Announces BMS Opt-in for Worldwide Rights of PRX005
11 Jul 2023 //
YAHOO FINANCE
Prothena Presents New Preclinical Data Supporting Best-in-Class Profile PRX012
31 Mar 2023 //
BUSINESSWIRE
Prothena Reports Topline Phase 1 Single Ascending Dose Study Results of PRX005
31 Jan 2023 //
BUSINESSWIRE
